Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
alert tags : Therapeutics save search
CEREVEL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cerevel Therapeutics - CERE
Published: 2024-01-26 (Crawled : 00:20) - prnewswire.com
TGH | $49.99 0.0% 1.2M
|
Finance
| Email alert
Add to watchlist
ABBV | News | $166.43 1.08% 2M
|
Health Technology
| Email alert
Add to watchlist
alert therapeutics
FREELINE THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Freeline Therapeutics Holdings plc - FRLN
Published: 2024-01-26 (Crawled : 00:20) - prnewswire.com
PWFL | $3.9 -3.94% 180K
|
Electronic Technology
| Email alert
Add to watchlist
FRLN | $6.48 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
alert therapeutics
BCLI LOSS ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - BCLI
Published: 2023-09-29 (Crawled : 00:20) - prnewswire.com
AVAV 4 | $151.34 3.16% 73K
|
Electronic Technology
| Email alert
Add to watchlist
BCLI | $0.5845 13.65% 790K
|
Health Technology
| Email alert
Add to watchlist
cell global therapeutics
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Entasis Therapeutics Holdings Inc.
Published: 2022-05-24 (Crawled : 23:00) - prnewswire.com
INVA | $14.94 1.7% 180K
|
Health Technology
|
| O: -0.84%
H: 1.96%
C: -2.02%
ETTX | $2.19 -0.46% 0.46%
|
Health Technology
|
| O: -0.46%
H: 0.46%
C: 0.46%
acquisition therapeutics
Investor Alert - The M&A Class Action Firm Announces an Investigation of Entasis Therapeutics Holdings Inc. - ETTX
Published: 2022-05-24 (Crawled : 01:00) - prnewswire.com
INVA | $14.94 1.7% 180K
|
Health Technology
|
| O: -3.51%
H: 0.0%
C: -3.86%
ETTX | $2.19 -0.46% 0.46%
|
Health Technology
|
| O: 0.0%
H: 0.92%
C: 0.92%
therapeutics
REVANCE THERAPEUTICS 96 HOUR DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against Revance Therapeutics, Inc. - RVNC
Published: 2022-02-05 (Crawled : 04:20) - prnewswire.com
RVNC | $3.76 -0.79% 570K
|
Health Technology
| Email alert
Add to watchlist
ces therapeutics 100 deadline
ALERT: Revance Therapeutics, Inc. Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit - RVNC
Published: 2021-12-31 (Crawled : 05:00) - prnewswire.com
RVNC | $3.76 -0.79% 570K
|
Health Technology
|
| O: -0.36%
H: 0.85%
C: -0.67%
therapeutics
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
INDO | $5.43 33.09% 10M
|
Energy Minerals
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
BSFC | $0.0822 27.64% 75M
|
Manufacturing
RWOD | $10.08 26.05% 5.6M
|
n/a
CHRO | $1.53 24.9% 100K
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
INSG | $2.98 23.14% 190K
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.